636. A Phase I Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Live, Attenuated, Quadrivalent Dengue Vaccine (V181)

por Russell, Kevin, Rupp, Richard E, Morales-Ramirez, Javier O, Diaz-Perez, Clemente, Andrews, Charles P, Lee, Andrew W, Finn, Tyler S, Cox, Kara, Russell, Amy Falk, Schaller, Margaret M, Martin, Jason C, Hyatt, Donna M, Gozlan-Kelner, Sabrina, Bili, Androniki, Coller, Beth-Ann
Publicado 2021

Sequential administration of Prevnar 13™ and PNEUMOVAX™ 23 in healthy participants 50 years of age and older

por Buchwald, Ulrike K., Andrews, Charles P., Ervin, John, Peterson, James T., Tamms, Gretchen M., Krupa, David, Ajiboye, Patrick, Roalfe, Lucy, Krick, Andrea L., Sterling, Tina M., Wang, Meihua, Martin, Jason C., Stek, Jon E., Kohn, Melvin A., Folaranmi, Temitope, Abeygunawardana, Chitrananda, Hartzel, Jonathan, Musey, Luwy K.
Publicado 2021

A phase I randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability, and immunogenicity of a live-attenuated quadrivalent dengue vaccine in flavivirus...

por Russell, Kevin L., Rupp, Richard E., Morales-Ramirez, Javier O., Diaz-Perez, Clemente, Andrews, Charles P., Lee, Andrew W., Finn, Tyler S., Cox, Kara S., Falk Russell, Amy, Schaller, Margaret M., Martin, Jason C., Hyatt, Donna M., Gozlan-Kelner, Sabrina, Bili, Androniki, Coller, Beth-Ann G.
Publicado 2022